EP2224915A4 - Compositions pharmaceutiques - Google Patents

Compositions pharmaceutiques

Info

Publication number: EP2224915A4
Authority: EP; European Patent Office
Prior art keywords: pharmaceutical composition; pharmaceutical; composition
Prior art date: 2007-12-17
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP08866252.3A

Other languages

German (de)

English (en)

Other versions

EP2224915A1 (fr

Inventor

Alfred Liang

Frank Matthews

Garth Boehm

Lijuan Tang

Frank Johnson

Joseph Stauffer

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Alpharma Pharmaceuticals LLC

Original Assignee

Alpharma Pharmaceuticals LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-12-17

Filing date

2008-12-16

Publication date

2014-01-22

2008-12-16 Application filed by Alpharma Pharmaceuticals LLC filed Critical Alpharma Pharmaceuticals LLC

2010-09-08 Publication of EP2224915A1 publication Critical patent/EP2224915A1/fr

2014-01-22 Publication of EP2224915A4 publication Critical patent/EP2224915A4/fr

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

Health & Medical Sciences (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EP08866252.3A 2007-12-17 2008-12-16 Compositions pharmaceutiques Withdrawn EP2224915A4 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US793507P	2007-12-17	2007-12-17
PCT/US2008/087043 WO2009085778A1 (fr)	2007-12-17	2008-12-16	Compositions pharmaceutiques

Publications (2)

Publication Number	Publication Date
EP2224915A1 EP2224915A1 (fr)	2010-09-08
EP2224915A4 true EP2224915A4 (fr)	2014-01-22

Family

ID=40824650

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP08866252.3A Withdrawn EP2224915A4 (fr)	2007-12-17	2008-12-16	Compositions pharmaceutiques

Country Status (4)

Country	Link
EP (1)	EP2224915A4 (fr)
AU (1)	AU2008343267A1 (fr)
CA (1)	CA2709950A1 (fr)
WO (1)	WO2009085778A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
OA12215A (en)	2000-02-08	2006-05-09	Euro Celtique Sa	Tamper-resistant oral opioid agonist formulations.
US7332182B2 (en)	2001-08-06	2008-02-19	Purdue Pharma L.P.	Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant
US7157103B2 (en)	2001-08-06	2007-01-02	Euro-Celtique S.A.	Pharmaceutical formulation containing irritant
US20030157168A1 (en)	2001-08-06	2003-08-21	Christopher Breder	Sequestered antagonist formulations
SI1414451T1 (sl)	2001-08-06	2009-10-31	Euro Celtique Sa	Formulacije opioidnega agonista s sproĹˇÄŤanja sposobnim in sekvestriranim antagonistom
US7842307B2 (en)	2001-08-06	2010-11-30	Purdue Pharma L.P.	Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
MY135852A (en)	2003-04-21	2008-07-31	Euro Celtique Sa	Pharmaceutical products
AU2008338439A1 (en) *	2007-12-17	2009-06-25	Alpharma Pharmaceuticals. Llc	Pharmaceutical composition
AU2008346870A1 (en) *	2007-12-17	2009-07-16	Alpharma Pharmaceuticals, Llc	Pharmaceutical composition
JP2012087101A (ja) *	2010-10-21	2012-05-10	Holger Hermann Lars	オピオイドおよびオピオイド拮抗薬を含む微粒子医薬組成物
EP3079661B1 (fr)	2013-12-11	2021-05-05	Algobate AG	Mono-préparation de naloxone
US10105360B2 (en)	2013-12-11	2018-10-23	Develco Pharma Schweiz Ag	Method and composition for the treatment of opioid induced constipation

Citations (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997033566A2 (fr) *	1996-03-12	1997-09-18	Alza Corporation	Composition et forme galenique contenant un antagoniste des opioides
WO2001058451A1 (fr) *	2000-02-08	2001-08-16	Euro-Celtique, S.A.	Formes orales inviolables d'agonistes de l'opioide
WO2004026283A1 (fr) *	2002-09-20	2004-04-01	Alpharma, Inc.	Sous-unite de sequestration et compositions et procedes associes
US20040202717A1 (en) *	2003-04-08	2004-10-14	Mehta Atul M.	Abuse-resistant oral dosage forms and method of use thereof
US20050191244A1 (en) *	2002-10-25	2005-09-01	Gruenenthal Gmbh	Abuse-resistant pharmaceutical dosage form
WO2007149438A2 (fr) *	2006-06-19	2007-12-27	Alpharma, Inc.	Compositions pharmaceutiques
WO2008027442A2 (fr) *	2006-08-30	2008-03-06	Theraquest Biosciences, Llc	Formulations pharmaceutiques orales anti-abus à base d'opioïdes et procédé d'utilisation
WO2008063301A2 (fr) *	2006-10-11	2008-05-29	Alpharma, Inc.	Compositions pharmaceutiques
WO2009032270A2 (fr) *	2007-09-04	2009-03-12	Alpharma, Inc.	Compositions pharmaceutiques
WO2009079518A1 (fr) *	2007-12-17	2009-06-25	Alpharma Pharmaceuticals. Llc	Composition pharmaceutique
WO2009088673A2 (fr) *	2007-12-17	2009-07-16	Alpharma Pharmaceuticals, Llc	Composition pharmaceutique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050106249A1 (en) *	2002-04-29	2005-05-19	Stephen Hwang	Once-a-day, oral, controlled-release, oxycodone dosage forms
US20050245557A1 (en) *	2003-10-15	2005-11-03	Pain Therapeutics, Inc.	Methods and materials useful for the treatment of arthritic conditions, inflammation associated with a chronic condition or chronic pain
PL1691892T3 (pl) *	2003-12-09	2007-07-31	Euro Celtique Sa	Odporna na fizyczne manipulowanie, współwytłaczana postać dawkowania zawierająca środek aktywny i środek przeciwdziałający oraz sposób wytwarzania tej postaci

2008
- 2008-12-16 EP EP08866252.3A patent/EP2224915A4/fr not_active Withdrawn
- 2008-12-16 WO PCT/US2008/087043 patent/WO2009085778A1/fr active Application Filing
- 2008-12-16 CA CA2709950A patent/CA2709950A1/fr not_active Abandoned
- 2008-12-16 AU AU2008343267A patent/AU2008343267A1/en not_active Abandoned

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997033566A2 (fr) *	1996-03-12	1997-09-18	Alza Corporation	Composition et forme galenique contenant un antagoniste des opioides
WO2001058451A1 (fr) *	2000-02-08	2001-08-16	Euro-Celtique, S.A.	Formes orales inviolables d'agonistes de l'opioide
WO2004026283A1 (fr) *	2002-09-20	2004-04-01	Alpharma, Inc.	Sous-unite de sequestration et compositions et procedes associes
US20050191244A1 (en) *	2002-10-25	2005-09-01	Gruenenthal Gmbh	Abuse-resistant pharmaceutical dosage form
US20040202717A1 (en) *	2003-04-08	2004-10-14	Mehta Atul M.	Abuse-resistant oral dosage forms and method of use thereof
WO2007149438A2 (fr) *	2006-06-19	2007-12-27	Alpharma, Inc.	Compositions pharmaceutiques
WO2008027442A2 (fr) *	2006-08-30	2008-03-06	Theraquest Biosciences, Llc	Formulations pharmaceutiques orales anti-abus à base d'opioïdes et procédé d'utilisation
WO2008063301A2 (fr) *	2006-10-11	2008-05-29	Alpharma, Inc.	Compositions pharmaceutiques
WO2009032270A2 (fr) *	2007-09-04	2009-03-12	Alpharma, Inc.	Compositions pharmaceutiques
WO2009079518A1 (fr) *	2007-12-17	2009-06-25	Alpharma Pharmaceuticals. Llc	Composition pharmaceutique
WO2009088673A2 (fr) *	2007-12-17	2009-07-16	Alpharma Pharmaceuticals, Llc	Composition pharmaceutique

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JOHNSON F ET AL: "(236) Relative bioavailability of plasma naltrexone from crushed ALO-01 (an investigational, abuse-deterrent, extended-release, morphine sulfate formulation with sequestered naltrexone) to a naltrexone oral solution", JOURNAL OF PAIN, SAUNDERS, PHILADELPHIA, PA, US, vol. 9, no. 4, 1 April 2008 (2008-04-01), pages 35, XP025871409, ISSN: 1526-5900, [retrieved on 20080401], DOI: 10.1016/J.JPAIN.2008.01.157 *
See also references of WO2009085778A1 *

Also Published As

Publication number	Publication date
CA2709950A1 (fr)	2009-07-09
WO2009085778A1 (fr)	2009-07-09
EP2224915A1 (fr)	2010-09-08
AU2008343267A1 (en)	2009-07-09

Publication	Publication Date	Title
HUS1800007I1 (hu)	2018-03-28	Gyógyászati készítmény
IL247741A0 (en)	2016-11-30	pharmaceutical preparations
EP2133095A4 (fr)	2012-09-26	Composition pharmaceutique
EP2133094A4 (fr)	2010-10-13	Composition pharmaceutique
IL201891A0 (en)	2010-06-16	Novel pharmaceutical composition
ZA200905224B (en)	2010-04-28	Pharmaceutical composition
EP2222313A4 (fr)	2011-02-16	Compositions pharmaceutiques
EP2116242A4 (fr)	2013-02-13	Nouvelle composition pharmaceutique
EP2224805A4 (fr)	2013-10-16	Composition pharmaceutique
EP2224915A4 (fr)	2014-01-22	Compositions pharmaceutiques
EP2268278A4 (fr)	2011-11-09	Composition pharmaceutique
EP2224808A4 (fr)	2013-11-27	Composition pharmaceutique
EP2146695A4 (fr)	2010-05-19	Compositions pharmaceutiques
HK1138774A1 (en)	2010-09-03	Pharmaceutical composition
GB0709811D0 (en)	2007-07-04	Pharmaceutical compositions
GB0707127D0 (en)	2007-05-23	Pharmaceutical compositions
EP2224806A4 (fr)	2014-02-19	Composition pharmaceutique
IL205975A0 (en)	2010-11-30	Pharmaceutical composition
GB0712454D0 (en)	2007-08-08	Pharmaceutical compositions
IL205931A0 (en)	2010-11-30	Pharmaceutical composition
GB0817969D0 (en)	2008-11-05	Pharmaceutical composition
GB2454923B (en)	2011-04-20	Pharmaceutical compositions
IL201394A0 (en)	2010-05-31	Niacin - based pharmaceutical compositions
GB0712558D0 (en)	2007-08-08	Pharmaceutical composition
GB0717036D0 (en)	2007-10-10	Pharmaceutical composition

Legal Events

Date	Code	Title	Description
2010-08-06	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2010-09-08	17P	Request for examination filed	Effective date: 20100624
2010-09-08	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
2010-09-08	AX	Request for extension of the european patent	Extension state: AL BA MK RS
2010-10-27	RIN1	Information on inventor provided before grant (corrected)	Inventor name: STAUFFER, JOSEPH Inventor name: JOHNSON, FRANK Inventor name: TANG, LIJUAN Inventor name: BOEHM, GARTH Inventor name: MATTHEWS, FRANK Inventor name: LIANG, ALFRED
2011-03-23	DAX	Request for extension of the european patent (deleted)
2014-01-22	A4	Supplementary search report drawn up and despatched	Effective date: 20140102
2014-01-22	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 45/06 20060101ALI20131217BHEP Ipc: A61K 31/485 20060101ALI20131217BHEP Ipc: A61K 9/50 20060101AFI20131217BHEP
2015-01-09	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2015-02-11	18D	Application deemed to be withdrawn	Effective date: 20140801